News

The growing market for self-administered injectables calls for better patient-training resources

A host of evaluation methodologies are defining ‘value’ in drug prices

Existing incentives continue to draw in new drug developers; payers begin to look at competitive markets to drive down drug costs

Vendors and service providers scramble to serve a growing market

Morris & Dickson publishes a family and company history

Sponsored by TGaS Advisors

More unusual gyrations as Mylan attempts to quell uprising against its pricing policies

Good Neighbor and Health Mart franchises trade top positions

Presidential politicking adds momentum to the growing backlash, and not just for Mylan

Substantial investments have been made, but beneficial results hard to identify, says ZS Associates

Life sciences marketers contend with a flood of new data sources—and the challenge of integrating them for meaningful results

Applying specialty-pharma techniques to a potentially mass-market drug

World Courier, Marken and QuickSTAT expand geographical reach

Company pairs up with Clemson University professor for online and in-person training

Vendors and users come together to standardize communication protocols

Healthcare research firm calls out the alarmist predictions over PCSK9s and other new drugs

‘Operation Black Market Meds’ involved New York State, Florida and federal investigators

CROs are expanding their scope of services

Advanced engineering brings powered, active control of temperature-sensitive shipments via ocean containers

Deal deepens Teva’s business in generics

Company invests $45 million for serialization- and cold-chain-ready capacity

While CDC steps up its analysis, private companies race to commercialize tests, vaccines and tracking mechanisms

Advent joins Thomas Lee Partners in ownership of the clinical, commercial outsourcer

Painkiller addicts buy street drugs that simulate well-known pharma brands